ABX464 was initially not designed/developed for COVID but for chronical infections like rheumatic arthritis, Crohn's disease, ... Covid just came along the way. All those other indications remain and offer much more potential. Abovax received Best Technology Award on European Mediscience Awards 2020. ABX464 has a huge potential.
T
I am buying 5000 share now I will expect it to hit 12 minimum by tomorrow market opening